A high-performance liquid chromatography with electrochemical detection (HPLC-ECD) system has been developed for determining aristolochic acids I and II (AA1 and AA2). HPLC using an octadecylsilica (ODS) column and a mobile phase of methanol-water-phosphoric acid (65:35:0.5, v/v/v) was conducted for the separation of the AA1 and AA2. Both of the chromatographic peak heights for AA1 and AA2 at the detection potential of −0.7 V vs. Ag/AgCl were found to be linearly related to the concentrations injected, ranging from 10 ng mL −1 to 50 µg mL −1 (r > 0.997). The detection limits (S/N = 3) of AA1 and AA2 were 3.4 and 3.1 ng mL −1 , respectively. Considering the detection limits, the present method makes it possible to be a purity test of the quantity of AA1 and AA2 contained as impurities in herbal medicines. The present HPLC-ECD was applied to determine AA1 and AA2 content in Radix et Rhizoma Asari and Radix Aristolochiae Fangchi.
Introduction
There were reports from Belgium of a severe renal disorder, initially called Chinese herb nephropathy (CHN), [1] [2] [3] which exhibits a rapidly progressive renal function deterioration and kidney scarring, resulting in end-stage renal disease. A further study showed that CHN appeared to be caused by the dramatic consequence substitution of the nontoxic herb Radix Stephaniae Tetrandrae by Radix Aristolochiae Fangchi rich in aristolochic acids (AAs), whereby AAs were strongly suspected to lead to this nephropathy. 4 In an animal experiment using Wistar rats, mitosis and necrosis of proximal tubules were induced by a single dose of 100 mg kg ¹1 AAs orally, 5 and proximal tubular atrophy and interstitial fibrosis were induced by subcutaneous administration of 10 mg kg ¹1 AAs for five days a week for 35 days. 6 With the acute toxicity of AAs, the lethal dose 50 (LD 50 ) of AAs in Wistar rats has been reported to range from 56 to 203 mg kg ¹1 orally. 7 Indeed, 0.65 « 0.56 mg g ¹1 AAs was determined in the problematic Chinese herbal preparation that led to CHN. 3 Therefore, this nephropathy, which is caused by AAsrich Chinese herbal medicine ingestion, has been termed aristolochic acid nephropathy (AAN). With the expanding use of herbal therapies in many countries, AAN has become a worldwide disease.
AA analogs, in which aristolochic acids I and II (AA1 and AA2 as shown in Fig. 1 ) are the major components, are present in many plants of the Aristolochia and Asarum species such as Aristolochia debilis Sieb. et Zucc, Aristolochia fangchi Y.C. Wu, and Asiasarum sieboldii F. Maekawa. 8, 9 Although herbs known to or suspected to contain aristolochic acid are no longer permitted in many countries, several AAN cases are regularly observed around the world. 4, 10, 11 As for the reason, in traditional Chinese medicines, some herbs share the same Chinese names, which may lead to problematic confusion. For instance, AA-containing Radix Aristolochiae Fangchi (Chinese name, Guang fang ji) is often mistakenly used because both the nontoxic herb Radix Stephaniae Tetrandrae (Fang ji) and Radix Aristolochiae Fangchi (Guang fang ji) are usually called Fangji. 12 Therefore, it is highly important to develop a sensitive and selective method to show the presence of AAs in crude herbal drugs and preparations in order to prevent AAN.
Several analytical methods have been employed to determine AAs such as high-performance liquid chromatography with ultraviolet detection (HPLC-UV), 13 mass spectrometry (LC/MS), [14] [15] [16] and fluorescence detection (HPLC-FL). 17 In the Japanese Pharmacopoeia, 16th edition (JP XVI), the purity tests of crude herbal drugs and preparations for AA1 are carried out using an HPLC-UV method. 18 In this purity test, the content of AA1 in a sample of crude Electrochemistry herbal drugs and preparations was not found or was less than 1.0 µg g ¹1 and was confirmed using an HPLC-UV method. A capillary electrophoresis with electrochemical detection (CE-ECD) in the oxidation mode at +1.2 V vs. Ag/AgCl was applied to determine AAs in Aristolochia plants. 19 However, many unknown peaks were observed close to AAs peaks on electrophoregram in an analysis of Aristolochia plants. 19 Thus, electrochemical detection in the oxidation mode would be unsuitable for determining AAs with high selectivity. A nitrophenyl group is ideally suited to electrochemical detection in the reduction mode. [20] [21] [22] [23] Especially, 2,4-dinitrofluorobenzene is utilized for the pre-and post-columns derivatization of amino acid in HPLC method, and the derivatization detection approach provides limits of detection in the low ppb range with a linearity of roughly three orders magnitude. 23 For the electrochemistry of AAs, it has been shown that the nitro function group in AAs is reduced to hydroxylamine on a pyrolytic graphite electrode in acidic media according to the electrochemical reduction reaction involved with 4-electrons and 2-protons (4e/2H + ). 12 Thus, it is expected that an HPLC with electrochemical detection (HPLC-ECD), by means of the electrochemical reduction of AAs, would provide a sensitive and selective method for the determination of AA1 and AA2 content in Chinese herbal medicines. By an HPLC-ECD method, a stringent purity test for AAs and quality control of Chinese herbal medicine would be performed in comparison with existing HPLC methods. However, no paper has been published on the determination of AA1 and AA2 by HPLC-ECD. In this report, an HPLC-ECD system to determine AA1 and AA2 with highsensitivity and -selectivity was developed, and it was applied to the determination of AA1 and AA2 in Chinese herbal medicines.
Experimental

Chemicals and reagents
AA1 and AA2 were purchased from LKT Laboratories, Inc. (MN, U.S.A.). 3,5-Di-tert-butyl-1,2-benzoquinone (DBBQ as shown in Fig. 1 ) was obtained from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Methanol (HPLC grade) and phosphoric acid were obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Other reagents were of reagent grade and available from commercial sources.
Sample preparation
In Table 1 , names of herbal medicine samples studied and their related medicines are listed with origin. In addition, Table 1 shows whether AAs are contained. Among herbal medicine listed in Table 1 , commercially available Radix et Rhizoma Asari, Radix Aristolochiae Fangchi, Caulis Akebiae, and Radix Aucklandiae, which were produced in China, were used as real herbal medicine samples.
To prepare a test solution of the herbal medicine, the abovementioned herbal medicine (0.4 g) was added to 10.0 mL of 75% methanol containing DBBQ as an internal standard (IS), shaken for 15 minutes, and filtered. This solution was used as the test solution, and was then diluted with a mixture of methanol-water-phosphoric acid (65:35:0.5, v/v/v) containing DBBQ, and passed through a membrane filter (pore size: 0.45 µm, 13A, Kurabo Industries Itd., Osaka, Japan). A 5-µL volume of the test solution was injected into the HPLC-ECD system.
Apparatus and HPLC conditions
The HPLC-ECD was comprised of a vacuum degasser (LC-26A, BAS, Tokyo), a pump (301M, Flom, Tokyo), an injector fitted with a 5 µL injection loop (7125, Rheodyne, CA, USA), a microbore ODS column (Capcell Pak C18 UG120, 150 mm © 1.0 mm i.d., 3 µm, Shiseido, Tokyo), a column oven (FT-1, BAS), and an electrochemical detector (LC-4C, BAS). The electrochemical cell (Radial flow cell, BAS) was constructed from a glassy carbon working electrode, an Ag/AgCl reference electrode, and a stainless steel auxiliary electrode. Methanol-water-phosphoric acid (65:35:0.5, v/v/v) was used as a mobile phase. The applied potential was ¹0.7 V vs. Ag/ AgCl, the flow rate was 25 µL min ¹1 , and the column temperature was 40°C. An internal standard method was used for the determination of AA1 and AA2 amounts in the sample solution, and DBBQ was used as the IS. The analog data of a chromatogram from the electrochemical detector were converted to digital chromatogram data by an A/D converter (24 bit, ChromatoMonitor, Nihon Filcon Co. Ltd., Tokyo); the digital data were recorded by a personal computer at sampling intervals of 0.1 s point ¹1 . The standard deviation (SD) of the area measurement in the chromatographic baseline noise (AMCBN) 24 and detection limits of AA1 and AA2 based on the ISO 11843-7 25, 26 were obtained using a commercial software (MAY2000, Yazawa, Tochigi, Japan) and used for the performance assessment of the present HPLC-ECD system.
Results and Discussion
HPLC-ECD for determining AA1 and AA2
Reverse-phase chromatography using an ODS column and a mobile phase of a methanol-water mixture with 0.5% phosphoric acid were utilized for the determination of AA1 and AA2. In order to select the optimal applied potential for determining AA1 and AA2 with sensitivity and selectivity, hydrodynamic voltammograms for AA1 and AA2 at 5.0 µg mL ¹1 were measured. As shown in Fig. 2 , AA1 and AA2 were reduced at potentials of less than ¹0.2 V vs. Ag/AgCl, and reduction waves at ¹0.6 V vs. Ag/AgCl were observed in the hydrodynamic voltammogram. For potentials more negative than ¹0.9 V vs. Ag/AgCl, chromatographic peak heights were increased, while chromatographic baseline noises were increased. Therefore, for a highly sensitive determination, without a loss of selectivity and reproducibility, the applied potential was set at ¹0.7 V vs. Ag/AgCl in the present study. A typical chromatogram for AA1 and AA2 at 10 µg mL ¹1 each and DBBQ (IS) is shown in Fig. 3A . The retention times of AA2, AA1, and DBBQ were 10.6, 13.8, and 20.2 min, respectively. The resolution (R s ) between AA2 and AA1, and that between AA1 and DBBQ were 3.5 and 5.9, respectively. The chromatographic peak heights of AA1 and AA2 were found to be linearly related to the AA1 and AA2 concentrations in the standard solution from 10 ng mL ¹1 to 50 µg mL ¹1 (r > 0.997) and 10 ng mL ¹1 to 50 µg mL ¹1 (r > 0.999), respectively. The standard solution at 5.0 µg mL ¹1 was determined five times with a relative standard deviation (RSD) of less than 2.3%. The detection limits of AA1 and AA2 (at the signal to noise ratio of 3, S/N = 3) for a single injection of the present method were 3.4 and 3.1 ng mL ¹1 , respectively. Meanwhile, based on the ISO 11843-7, 25,26 detection limits of AA1 and AA2 were also obtained; the results were 3.6 and 3.4 ng mL ¹1 , respectively.
The sensitivity was compared with other available methods for determining AA1 as shown in Table 2 . The present HPLC-ECD is the most sensitive technique among the above methods.
Determination of AA1 and AA2 in Chinese herbal
medicine Although the nontoxic herb Akebia quinata Decaisne (Chinese name, Mu tong) is normally used to produce Caulis Akebiae, AAcontaining Aristolochia manshuriensis Kom (Guan mu tong) is often mistakenly used to produce Caulis Akebiae. 27 In a similar manner, although the nontoxic herb Saussurea lappa Clarke (Mu xiang) is normally used to produce Radix Aucklandiae, AAcontaining Aristolochia debilis Sieb. et Zucc (Qing mu xiang) and Aristolochia yunnanensis Franch (Nan mu xiang) are often mistakenly used to produce Radix Aucklandiae. 27 First, the present HPLC-ECD was applied to a purity test of the quantity of AA1 and AA2 contained as impurities in Caulis Akebiae and Radix Aucklandiae. The chromatograms were obtained following the injection of a 5 µL sample solution of the crude herbal drug Caulis Akebiae, and the crude herbal drug Radix Aucklandiae (data not shown). AA1 and AA2 in the Caulis Akebiae and Radix Aucklandiae were not detected by the present HPLC-ECD. Thus, considering the detection limits by the present HPLC-ECD, the AA1 and AA2 contents were less than 85 and 78 ng g ¹1 , respectively, in the Caulis Akebiae and Radix Aucklandiae studied.
Next, the present HPLC-ECD system was applied for the determination of AA1 and AA2 in Radix Aristolochiae Fangchi and Radix et Rhizoma Asari. The chromatogram in Fig. 3B was obtained following the injection of a 5 µL sample solution from a Radix et Rhizoma Asari. The presented HPLC-ECD system detected AA1 and AA2 in both the Radix Aristolochiae Fangchi and Radix et Rhizoma Asari. AA1 and AA2 contents in the Radix et Rhizoma Electrochemistry, 82 (6), 444-447 (2014) Asari and Radix Aristolochiae Fangchi along with the recovery data of AA1 and AA2 are listed in Table 3 . AA1 and AA2 contents were determined with less than 2.5% RSD (n = 5). Recovery tests of AA1 and AA2 were made using standard AA1 and AA2 spiked in the Radix Aristolochiae Fangchi and Radix et Rhizoma Asari; the results were 98.3-99.5%, and the repeatability was less than 2.0% RSD (n = 5), indicating that the present HPLC-ECD was uninfluenced by the other components in the samples and was quite adequate, and precise for measuring AA1 and AA2. Radix et Rhizoma Asari is normally produced using a root and rhizome of Asiasarum sieboldii F. Maekawa which does not contain AAs, and is never mixed with the aerial part that contains AAs. 18 Because both AA1 and AA2 were detected in the crude herbal drug of Radix et Rhizoma Asari studied, it can be expected that an aerial part of Asiasarum sieboldii F. Maekawa is mixed to a root and rhizome.
Conclusion
In this study, HPLC-ECD has been established as a sensitive and selective method for the determination of AA1 and AA2. Further, AA1 and AA2 in Radix et Rhizoma Asari and Radix Aristolochiae Fangchi content were determined with accuracy and precision by the present HPLC-ECD system. Moreover, the signal responses to AA1 and AA2 in the real samples from the glassy carbon working electrode were found to remain stable for 3 months (15 samples assays day ¹1 ) without polishing the working electrode surface. The separation between AA2 and AA1 in the present HPLC-ECD were also found to remain stable for 3 months using a same column. In the JP XVI, the HPLC-UV method, which requires a detection limit of 40 ng mL ¹1 in an AA1 standard solution as a sign of detectability, is used to confirm whether the content of AA1 in a sample of crude herbal drugs and preparations are less than 1.0 µg g ¹1 . Considering the detection limits by the present HPLC-ECD, our method makes it possible to be a purity test whether the content of AA1 is less than 85 ng g ¹1 in the sample. This value was calculated by dividing the detection limit of AA1 by the present method (3.4 ng mL ¹1 ) by the amount of crude herbal drug in test solution (40 mg mL ¹1 ). The present HPLC-ECD, being 10 times more sensitive in comparison to the official HPLC-UV, would be useful for checking the presence of AA1 and/or AA2 in crude herbal drugs, preparations, and health supplements. Table 3 . Contents of aristolochic acids I (AA1) and II (AA2) in Chinese herbal medicines studied and recovered from these herbal medicines spiked with AA1 and AA2 standards.
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